Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18633 | 476 | 35.1 | 42% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1047 | 9598 | ULTRASONIC VOCALIZATION//PLAY FIGHTING//ISOLATION REARING |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ROSS STUDIES NEURAL BIRTH DEFECTS | Address | 11 | 57% | 3% | 13 |
2 | PRENATAL DIAZEPAM | Author keyword | 6 | 80% | 1% | 4 |
3 | NEUROBEHAVIORAL TERATOGENICITY | Author keyword | 4 | 67% | 1% | 4 |
4 | NICOTINE THERAPY | Author keyword | 3 | 60% | 1% | 3 |
5 | HIPPOCAMPAL CHOLINERGIC INNERVATION | Author keyword | 2 | 67% | 0% | 2 |
6 | PRENATAL OXAZEPAM | Author keyword | 2 | 67% | 0% | 2 |
7 | CIRCLING TRAINING | Author keyword | 2 | 50% | 1% | 3 |
8 | BEHAVIOURAL DIFFERENTIATION | Author keyword | 1 | 50% | 0% | 2 |
9 | CHOLINERGIC INNERVATIONS | Author keyword | 1 | 100% | 0% | 2 |
10 | FOSTERING PROCEDURE | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SEPTOHIPPOCAMPAL CHOLINERGIC INNERVATIONS | 15 | 88% | 1% | 7 |
2 | BRAIN RECEPTORS | 6 | 53% | 2% | 8 |
3 | HIPPOCAMPAL PKC | 5 | 63% | 1% | 5 |
4 | NEURONAL DEFICITS | 3 | 50% | 1% | 5 |
5 | NURSING RATS | 3 | 57% | 1% | 4 |
6 | PRENATAL OXAZEPAM | 3 | 60% | 1% | 3 |
7 | DIAZEPAM EXPOSURE | 2 | 32% | 1% | 6 |
8 | DEVELOPING ORGANISM | 2 | 67% | 0% | 2 |
9 | NEUROTROPIC DRUGS | 2 | 67% | 0% | 2 |
10 | PKC GAMMA IMMUNOREACTIVITY | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
BENZODIAZEPINES - INFLUENCE ON THE DEVELOPING BRAIN | 1988 | 71 | 46 | 39% |
PERINATAL NEUROTOXICOLOGY OF PSYCHOTROPIC-DRUGS | 1987 | 17 | 23 | 57% |
BEHAVIORAL-CHANGES PRODUCED IN RATS BY DEVELOPMENTAL EXPOSURE TO FLUMAZENIL, A BENZODIAZEPINE RECEPTOR ANTAGONIST | 1993 | 8 | 10 | 50% |
Developmental striatal critical period of activity-dependent plasticity is also a window of susceptibility for haloperidol induced adult motor alterations | 2009 | 4 | 45 | 18% |
Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: Experimental and clinical aspects | 2004 | 35 | 458 | 11% |
BENZODIAZEPINES AND THE DEVELOPING RAT - A CRITICAL-REVIEW | 1985 | 56 | 59 | 29% |
On mouse pups and their lactating dams: Behavioral consequences of early exposure to oxazepam and interacting factors | 1996 | 5 | 99 | 26% |
LONG-LASTING EFFECTS OF EARLY BARBITURATES ON CENTRAL NERVOUS-SYSTEM AND BEHAVIOR | 1983 | 38 | 30 | 40% |
BRAIN-CELL ACQUISITION AND NEUROTROPIC DRUGS WITH SPECIAL REFERENCE TO FUNCTIONAL TERATOGENESIS | 1988 | 23 | 15 | 20% |
FUNCTIONAL-EFFECTS OF GLUCOCORTICOID EXPOSURE DURING FETAL LIFE | 1993 | 6 | 36 | 17% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ROSS STUDIES NEURAL BIRTH DEFECTS | 11 | 57% | 2.7% | 13 |
2 | HOSP P GIACCONE | 1 | 50% | 0.2% | 1 |
3 | ZOOL EMBRYOL | 1 | 50% | 0.2% | 1 |
4 | BEHAV PATHOPHYSIOL SECT | 1 | 17% | 0.6% | 3 |
5 | CNR2M | 0 | 33% | 0.2% | 1 |
6 | COMPARAT PSYCHOL SECT | 0 | 33% | 0.2% | 1 |
7 | HADASSAH MED ANAT EMBRYOL | 0 | 33% | 0.2% | 1 |
8 | LIFE BRAIN HERTIE FDN | 0 | 33% | 0.2% | 1 |
9 | TRM LEIPZIG | 0 | 20% | 0.2% | 1 |
10 | MED NEUROBIOL MED | 0 | 17% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000194149 | MYOCLONIC TWITCHING//PROGRAM BEHAV COGNIT NEUROSCI//NEONATAL CLOMIPRAMINE |
2 | 0.0000102317 | EUROPEAN DIRECTIVE 98 79 EC//WATER SOLUBLE CONDUCTIVE POLYMER//HOMOGENEOUS COMPETITIVE IMMUNOASSAY |
3 | 0.0000097334 | DEVELOPMENTAL NEUROTOXICITY TESTING//FOOD AGCY//FUNCTIONAL OBSERVATIONAL BATTERY FOB |
4 | 0.0000096771 | INFANT DOSE//DEGRA//PREGNANCY POSTPARTUM MOOD DISORDERS PROGRAM |
5 | 0.0000096219 | EMORY EPILEPSY PROGRAM//KERALA REGISTRY EPILEPSY PREGNANCY//FETAL HYDANTOIN SYNDROME |
6 | 0.0000079117 | BRETAZENIL//ABECARNIL//FLUMAZENIL |
7 | 0.0000069082 | MOTOR SEIZURES//MED 3 PATHOPHYSIOL//POSTSYNAPTIC ELEMENT |
8 | 0.0000068027 | ULTRASONIC VOCALIZATION//ULTRASONIC VOCALIZATIONS//50 KHZ CALLS |
9 | 0.0000068006 | ORNITHINE DECARBOXYLASE IN DEVELOPING BRAIN//ADENYLYL CYCLASE SIGNALING//NORADRENERGIC SYSTEMS |
10 | 0.0000059336 | OPIOID GROWTH FACTOR//OPIOID GROWTH FACTOR RECEPTOR//PRENATAL MORPHINE |